Position
Executive Vice President
Company
Alnylam Pharmaceuticals
CambridgeBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
On November 4, 2026, Alnylam Pharmaceuticals announced the departure of Tolga Tanguler from his role as Executive Vice President, Chief Commercialization Officer, effective December 2026. A written agreement regarding the terms of his departure is expected to be finalized before his separation date. The company continues to advance its strategic initiatives while managing executive transitions.
Quick answer
Alnylam Pharmaceuticals Announces Departure of Executive Vice President (November 5, 2026). Alnylam Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- What did Alnylam Pharmaceuticals announce on November 5, 2026?
- On November 4, 2026, Alnylam Pharmaceuticals announced the departure of Tolga Tanguler from his role as Executive Vice President, Chief Commercialization Officer, effective December 2026. A written agreement regarding the terms of his departure is expected to be finalized before his separation date.
- What does Alnylam Pharmaceuticals do?
- Alnylam Pharmaceuticals, Inc. is a leading RNAi therapeutics company focused on developing novel medicines to treat genetically defined diseases.
- Where is Alnylam Pharmaceuticals based?
- Alnylam Pharmaceuticals is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Pfizer (November 5, 2026), AbbVie Inc. (November 2, 2026), AlzeCure Pharma (November 1, 2026) and Nurix Therapeutics (November 12, 2026) also announced leadership changes within 45 days of Alnylam Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pfizer Appoints Cecile Guegan as CFO and Omnicom Health Names Tom Schwenger as CEO (November 5, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- AlzeCure Pharma Appoints Johan Sandin as Acting CEO and Pontus Forsell as Deputy CEO (November 1, 2026)
- Nurix Therapeutics Appoints Arati V. Rao, M.D., as Chief Medical Officer (November 12, 2026)
- GH Research PLC Appoints Vanina Popova as Chief Development Officer (November 13, 2026)
- Bristol Myers Squibb Appoints Cristian Massacesi as Head of R&D (November 15, 2026)
Who to call at Alnylam Pharmaceuticals, and when
A new leader at Alnylam Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Alnylam Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alnylam Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alnylam Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alnylam Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alnylam Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.